eLearning: Measuring treatment success and failure
Uwe Reuter discusses how to assess the efficacy of migraine treatment and when to change treatment plans.
In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. NACCME designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was launched on July 20, 2021. The data were correct at time of publication and no further updates have been made to the content
After taking part in this case study, you will be able to:
- Describe the efficacy endpoints for acute migraine treatments and how these should inform treatment decisions in clinical practice.
- Utilize patient-reported outcome tools to assess treatment efficacy.